A novel method to access rctt-1,2,3,4-tetrakis-(4'-carboxyphenyl)-cyclobutane in quantitative yield from an environmentally benign route is presented. The cyclobutane derivative is demonstrated as a potential candidate to serve as an organic building block for making co-crystal and MOF.
No takes yet. Share an insight, caveat, or question.
Kole et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: